46results about How to "Improve biochemical indicators" patented technology

The invention provides a modular sludge thermal hydrolysis treatment method and device. The sludge thermal hydrolysis treatment device comprises a thermal hydrolysis reaction kettle, a cooling jackettank and a measuring bin, and the measuring bin, the thermal hydrolysis reaction kettle and the cooling jacket tank communicate sequentially. The modular sludge thermal hydrolysis treatment device andmethod have the beneficial effects that: 1, sludge is subjected to a thermal hydrolysis reaction, so that the biodegradability of the sludge is greatly improved, the dehydration property of the sludge is greatly improved, poisonous and harmful pathogenic bacteria and toxic substances in the sludge are killed, and the reduction, harmlessness and recycle of the sludge are realized; 2, no alkaline agents are added in the process, so that the temperature and pressure of sludge thermal hydrolysis treatment are greatly reduced, the equipment grade, energy consumption and cost are reduced, and the treatment efficiency is increased; 3, the biochemical indexes of thermal hydrolysis slurry of a sludge thermal hydrolysis treatment process are increased, and the B/C ratio of the biochemical indexes is increased from 0.24 to 0.5; and 4, due to the adoption of the sludge thermal hydrolysis treatment process, the concentration of odor in the reaction kettle is greatly reduced from the source.

The present invention discloses an application of corydalis saxicola and a preparation thereof in treating non-alcoholic fatty liver diseases and/or non-alcoholic steatohepatitis. According to the invention, through a large amount of experimental screening, it is found that corydalis saxicola total alkaloids have good effects of reducing synthesis in fatty acid cells, and can reduce the levels ofTG, TC, LDL cholesterol, HDL cholesterol and free fatty acid induced by HFD. Animal anatomical experiments show that the corydalis saxicola total alkaloids can effectively reduce the weight of livers,and pathological sections show that liver tissues are well protected. In addition clinical experiments show that corydalis saxicola total alkaloid capsules can obviously improve biochemical indexes and imaging evaluation results of fatty liver patients. The drug-induced liver injury experimental results show that the corydalis saxicola total alkali capsules can obviously improve drug-induced liver injury and have the effect of preventing liver injury.

The invention relates to a chicken feed, and especially relates to a feed for increasing the egg laying rate of under-forest free-range chickens. The feed is prepared from the following raw materials in parts by weight: 5-7 parts of wheat bran, 15-20 parts of soybean meal, 3-6 parts of peanut meal, 60-64 part of corn, 1-1.5 parts of bone meal, 0.1-0.2 part of a compound enzyme, 0.02-0.05 part of vitamins, 0.2-0.3 part of fluorine-free calcium hydrogen phosphate, 0.05-0.1 part of methionine, 0.2-0.4 part of table salt, 0.5-0.6 part of radix astragali, 0.6-0.7 part of codonopsis pilosula, 0.2-0.4 part of radix scutellariae, 0.5-0.7 part of honeysuckle, 0.3-0.5 part of agastache rugosus, and 0.5-0.8 part of hawthorn. The feed for increasing the egg laying rate of the under-forest free-range chickens can increase the food intake, egg laying amount and egg quality of laying hens, improves the blood biochemical index, enhances body immunity and reduces the death and culling rate, and eggs have no antibiotic residues.

A hericium erinaceus mycelium polysaccharide with the effect of preventing and treating senile dementia and a preparation method are disclosed. Hericium erinaceus mycelium obtained through a liquid submerged fermentation technology serves as a raw material, the neuroprotective effect serves as an evaluation standard, and the novel purified hericium erinaceus mycelium polysaccharide is obtained through extraction, separation and purification, and is composed of six monosaccharides including fucose, galactose, xylose, glucose, mannose and glucuronic acid; and experiments prove that in APP/PS1 mice, the hericium erinaceus mycelium purified polysaccharide obtained in the invention can obviously shorten platform searching time and movement distance of the mice, improve platform jumping staying time of the mice, and reduce platform jumping-off times, and has effects of improving the cognition and memory ability of APP/PS1 mice, effectively reducing the levels of Abeta1-42, Tau (phospo S396) and 4-HNE in hippocampal regions of the mice, relieving AD pathological symptoms and improving the cholinergic system and the antioxidant ability.

The invention provides a hypertension liver-yang hyperactivity rat model discrimination method. According to the discrimination method, discrimination indexes are comprehensive, and special material groups generated in the hypertension liver-yang hyperactivity occurrence and development process are included. The method comprises the steps that a hypertension liver-yang hyperactivity rat model is copied as a disease group, macroscopic and biochemical physical indexes are measured, data is selected and brought into the hypertension liver-yang hyperactivity rat PLS regression model, if the disease group and the model group in a PLS two-dimensional score plot are separated, the built hypertension liver-yang hyperactivity rat model is successful, and if not, the built hypertension liver-yang hyperactivity rat model is not successful.

The invention provides a medicine for treating the vascular endothelial injury, the stenosis and the occlusion of the heart, the brain and the kidney mainly, which relates to a medicine of traditional Chinese medicines for treating diseases in the aspect of blood vessels. The medicine for treating the vascular endothelial injury, the stenosis and the occlusion of the heart, the brain and the kidney mainly is prepared by the following raw materials: 1 to 3 parts of radix salviae miltiorrhizae, 0.5 to 2 parts of radix notoginseng, 0.5 to 2 parts of leech, 0.5 to 2 parts of land tortoise plastron, 0.5 to 2 parts of crude turtle shell, 0.5 to 2 parts of scorpio, 0.5 to 2 parts of rhizoma alismatis, 0.5 to 2 parts of sea cucumber, 0.4 to 1.2 parts of ginseng and 0.1 to 0.4 parts of bear gall powder; when the medicine for treating the vascular endothelial injury, the stenosis and the occlusion of the heart, the brain and the kidney mainly is prepared, liquor is obtained after the operations of conventional alcohol extraction and water extraction are carried out on the raw materials except for the radix notoginseng, the sea cucumber and the bear gall; and the liquor is concentrated to clear paste of which the relative density is 1.32 to 1.40 (50 DEG C), then the clear paste is stirred with the pulverized matters of the radix notoginseng, the sea cucumber and the bear gall, and the mixture is dried so as to prepare particulate matters containing 17.4 percent of total sugar, 13.8 percent of protein, 180mg/100g of total flavone and 559mg/100g of total saponin. The medicine for treating the vascular endothelial injury, the stenosis and the occlusion of the heart, the brain and the kidney mainly has the following beneficial effects that the medicine for treating the vascular endothelial injury, the stenosis and the occlusion of the heart, the brain and the kidney mainly has a high curative effect, and no toxic or side effect, and is low in cost, and the phenomenon of relapse does not occur after healing; and by 69 cases of clinical trial, the effective rate is 99 percent, and the cure rate is 65 percent.

The invention provides a feed enzyme preparation capable of reducing diarrhea of weaned piglets. The feed enzyme preparation includes a complex enzyme, tea polyphenol and a carrier; the complex enzymeincludes 2,000 U/g of glucose oxidase, 3,000 U/g of amylase, 8,000 U/g of acid protease, 2,000 U/g of acid mannanase and 10,000 U/g of xylanase; and the carrier includes one or more of corn starch, mountain flour, medical stone or rice bran. A preparation method of the feed enzyme preparation includes the following steps: weighing each component of the complex enzyme preparation in proportion; uniformly mixing each component of the complex enzyme, and adding the tea polyphenol and the carrier into a double-shaft efficient mixer to mix, mixing time being 10-15 min; and performing mixing uniformity detection on a finished product after mixing, and ensuring that the coefficient of variation is less than or equal to 5%. The feed enzyme preparation can enhance the growing performance of weanedpiglets and reduce feed-meat ratio and diarrhea rate, and is an eco-friendly additive.

The invention provides application of peach gum polysaccharide to preparing a drug or a healthcare product used for treating or preventing nephritis and a pharmaceutical composition, and belongs to the technical field of traditional Chinese medicines. The inventor finds through the research that the peach gum polysaccharide effectively improves the biochemical criterion of nephritis, improves theimmunity, diminishes the inflammatory reaction, recovers the vigor of renal corpuscle, has a certain bacteriostatic action, and can be used to treat diseases of the urinary system like nephritis. Thepeach gum polysaccharide can be applied separately or together with other drugs to prepare the drug or the healthcare product for treating or preventing related diseases like renal corpuscle injuries,and can be used to alleviate the injuries of the renal corpuscle cells caused by other drugs, and provides a novel treatment means and thinking for the diseases caused by the injuries of the renal corpuscle cells.

The invention discloses an application of a Zhenlong refreshing pharmaceutical composition in preparation of a medicine for treating diabetic peripheral neuropathy. A Zhenlong refreshing preparation is traditionally used for treating acute cerebral infarction, carotid atherosclerosis plaque, apoplexy sequela, etc. Pharmacological experiments and clinical observations prove that the Zhenlong refreshing pharmaceutical composition disclosed by the invention comprises a Zhenlong refreshing capsule and a Zhenlong refreshing pharmaceutical composition prepared by an improved process, the Zhenlong refreshing pharmaceutical composition obviously perfects the symptoms of a nervous system of a DNP (diabetic peripheral neuropathy) patient and can significantly improve the nerve conduction velocity and perfect a variety of biochemical indexes, so that the Zhenlong refreshing pharmaceutical composition can be used for treating and preventing DPN.

The invention relates to the technical field of traditional Chinese medicine compositions, in particular to a traditional Chinese medicine composition for treating hand-foot-and-mouth disease. The traditional Chinese medicine composition comprises, by weight, raw gypsum 8-12 g, radix scutellariae 1-5 g, flos lonicerae 4-8 g, radix isatidis 4-8 g, fructus arctii 1-5 g, periostracum cicada 1-5 g, common ducksmeat herbs 1-5 g, radix lithospermi 1-5 g, radix paeoniae rubra 1-5 g, agastache rugosus 1-5 g, american ginseng 1-3 g, antelope horn powder 0.1-0.5 g and born licorice 1-3 g. The traditional Chinese medicine composition for treating the hand-foot-and-mouth disease can relieve the clinical symptoms, quickly achieve the effect, shorten the disease course, improve the biochemical index, prevent severe cases from developing to critical cases and improve the cure rate.

The invention relates to a low-temperature-resistant rice seedling raising substrate and a preparation method thereof. The low-temperature-resistant rice seedling raising substrate comprises the following components in parts by weight: 50-60 parts of crop straw, 20-30 parts of livestock manure, 20-30 parts of juice production residues, 0.1-0.2 part of a fermentation inoculant, 10-15 parts of a filler, 0.5-1.0 part of a water-retaining agent and 0.1-0.2 part of a cold-resistant conditioning agent. The cold-resistant conditioning agent and other components with a heat preservation function are added into the rice seedling raising substrate, so that the germination rate of rice under the cold condition is remarkably increased, and the inhibition effect of cold stress on rice growth is relieved.

An orally taken Chinese medicine containing astragalose and chuanxiongzine for treating cerebral thrombosis, cerebral hemorrhage and their sequelae is prepared from astragalus root and Chuan-xiong rhizome through respectively extracting. Their extracting processes are also disclosed.

The invention discloses a composition for prevention and treatment on viral infectious myocarditis. Active ingredients of the composition comprise Trefolane A and Tubeimoside A in a weight proportion of 1: 1 to 20: 1. Trefolane A and Tubeimoside A have good effects of improving general conditions, a survival rate, serum malondialdehyde (M DA) and serum nitric oxide (NO) of Coxsackie virus-infected myocarditis and have significant effects of prevention and treatment on Coxsackie virus-infected myocarditis.

The invention discloses application of a CTSG (cathepsin G) cell factor in the preparation of medicaments to treat hepatic failure. Death of mass hepatic cells occurs during the course of hepatic failure; the CTSG cell factor helps overcome the aforementioned problem. CTSG JNK (c-Jun N-terminal kinase) is one of MAPK (mitogen-activated protein kinase) family members; JNK pathway can inhibit apoptosis of hepatic cells by regulating the expression of CTSG. The CTSG cell factor can be applied to the preparation of medicaments to treat hepatic failure to significantly increase biochemical indexesof a patient, reduce bilirubin level, lower aminotransferase, improve the coagulation function, inhibit cell apoptosis, promote the regeneration of hepatic cells and bile duct cells, prevent occurrence of fatal complications, such as massive alimentary tract bleeding, severe hepatic encephalopathy and hepatorenal syndrome, extend the survival time of the patient significantly, and increase the survival rate.